Feeds › Ownership stakes (13D / 13G)
Ownership stakes (13D / 13G)
Investors who own more than 5% of a company, from activists (13D) to passive holders (13G).
About this data
- What it is
- An investor who owns more than 5% of a public company must say so. Investors who may try to influence the company, such as activists, file the longer Schedule 13D; passive holders file the shorter Schedule 13G.
- Who files it
- The investor, within days of crossing 5%, and again whenever the stake changes materially.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- 13G filings are far more common than 13D. A 13D usually means the investor intends to push for changes, so it tends to get more attention.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Filings per day, last 30 days
13D (activist) 13G (passive)
Latest ownership filings
Showing: ticker CLPT
| Filed | ScheduleBoth report a stake of more than 5%. A 13D is filed by investors who may try to influence the company, such as activists; a 13G by passive holders. | Company | Investor | Shares | % of shares | Filing |
|---|---|---|---|---|---|---|
| Nov 3, 2026 | SCHEDULE 13G/A (amended) | CLPT ClearPoint Neuro Inc. | Patricia Winter | 167,000 | 0.0% | SCHEDULE 13G/A ↗ |
| Nov 3, 2026 | SCHEDULE 13G/A (amended) | CLPT ClearPoint Neuro Inc. | Michael Bigger | 2.60M | 8.1% | SCHEDULE 13G/A ↗ |
| Nov 3, 2026 | SCHEDULE 13G/A (amended) | CLPT ClearPoint Neuro Inc. | District 2 Holdings LLC | 315,808 | 0.0% | SCHEDULE 13G/A ↗ |
| Nov 3, 2026 | SCHEDULE 13G/A (amended) | CLPT ClearPoint Neuro Inc. | District 2 GP LLC | 315,808 | 0.0% | SCHEDULE 13G/A ↗ |
| Nov 3, 2026 | SCHEDULE 13G/A (amended) | CLPT ClearPoint Neuro Inc. | District 2 Capital LP | 315,808 | 0.0% | SCHEDULE 13G/A ↗ |
| Nov 3, 2026 | SCHEDULE 13G/A (amended) | CLPT ClearPoint Neuro Inc. | District 2 Capital Fund LP | 315,808 | 0.0% | SCHEDULE 13G/A ↗ |
| Nov 3, 2026 | SCHEDULE 13G/A (amended) | CLPT ClearPoint Neuro Inc. | Bigger Capital Fund GP, LLC | 1.71M | 5.3% | SCHEDULE 13G/A ↗ |
| Nov 3, 2026 | SCHEDULE 13G/A (amended) | CLPT ClearPoint Neuro Inc. | Bigger Capital Fund L P | 1.71M | 5.3% | SCHEDULE 13G/A ↗ |
| Aug 12, 2026 | SCHEDULE 13G/A (amended) | CLPT ClearPoint Neuro Inc. | Michael A. Kaufman | 2.38M | 7.8% | SCHEDULE 13G/A ↗ |
| Aug 12, 2026 | SCHEDULE 13G/A (amended) | CLPT ClearPoint Neuro Inc. | MAK Capital Fund LP | 2.38M | 7.8% | SCHEDULE 13G/A ↗ |
| Aug 12, 2026 | SCHEDULE 13G/A (amended) | CLPT ClearPoint Neuro Inc. | Mak Capital One LLC | 2.38M | 7.8% | SCHEDULE 13G/A ↗ |
| Aug 4, 2026 | SCHEDULE 13G/A (amended) | CLPT ClearPoint Neuro Inc. | Patricia Winter | 167,000 | 0.0% | SCHEDULE 13G/A ↗ |
| Aug 4, 2026 | SCHEDULE 13G/A (amended) | CLPT ClearPoint Neuro Inc. | Michael Bigger | 2.27M | 7.5% | SCHEDULE 13G/A ↗ |
| Aug 4, 2026 | SCHEDULE 13G/A (amended) | CLPT ClearPoint Neuro Inc. | District 2 Holdings LLC | 295,196 | 0.0% | SCHEDULE 13G/A ↗ |
| Aug 4, 2026 | SCHEDULE 13G/A (amended) | CLPT ClearPoint Neuro Inc. | District 2 GP LLC | 295,196 | 0.0% | SCHEDULE 13G/A ↗ |
| Aug 4, 2026 | SCHEDULE 13G/A (amended) | CLPT ClearPoint Neuro Inc. | District 2 Capital LP | 295,196 | 0.0% | SCHEDULE 13G/A ↗ |
| Aug 4, 2026 | SCHEDULE 13G/A (amended) | CLPT ClearPoint Neuro Inc. | District 2 Capital Fund LP | 295,196 | 0.0% | SCHEDULE 13G/A ↗ |
| Aug 4, 2026 | SCHEDULE 13G/A (amended) | CLPT ClearPoint Neuro Inc. | Bigger Capital Fund GP, LLC | 1.41M | 4.6% | SCHEDULE 13G/A ↗ |
| Aug 4, 2026 | SCHEDULE 13G/A (amended) | CLPT ClearPoint Neuro Inc. | Bigger Capital Fund L P | 1.41M | 4.6% | SCHEDULE 13G/A ↗ |
| Jul 27, 2026 | SCHEDULE 13G/A (amended) | CLPT ClearPoint Neuro Inc. | BlackRock, Inc. | 2.12M | 7.1% | SCHEDULE 13G/A ↗ |
| May 15, 2026 | SCHEDULE 13G/A (amended) | CLPT ClearPoint Neuro Inc. | Michael A. Kaufman | 1.90M | 6.3% | SCHEDULE 13G/A ↗ |
| May 15, 2026 | SCHEDULE 13G/A (amended) | CLPT ClearPoint Neuro Inc. | Mak Capital One LLC | 1.90M | 6.3% | SCHEDULE 13G/A ↗ |
| May 15, 2026 | SCHEDULE 13G/A (amended) | CLPT ClearPoint Neuro Inc. | MAK Capital Fund LP | 1.90M | 6.3% | SCHEDULE 13G/A ↗ |
| Apr 20, 2026 | SCHEDULE 13G/A (amended) | CLPT ClearPoint Neuro Inc. | Patricia Winter | 167,000 | 0.0% | SCHEDULE 13G/A ↗ |
| Apr 20, 2026 | SCHEDULE 13G/A (amended) | CLPT ClearPoint Neuro Inc. | Michael Bigger | 2.26M | 7.5% | SCHEDULE 13G/A ↗ |
| Apr 20, 2026 | SCHEDULE 13G/A (amended) | CLPT ClearPoint Neuro Inc. | District 2 Holdings LLC | 341,696 | 1.1% | SCHEDULE 13G/A ↗ |
| Apr 20, 2026 | SCHEDULE 13G/A (amended) | CLPT ClearPoint Neuro Inc. | District 2 GP LLC | 341,696 | 1.1% | SCHEDULE 13G/A ↗ |
| Apr 20, 2026 | SCHEDULE 13G/A (amended) | CLPT ClearPoint Neuro Inc. | District 2 Capital LP | 341,696 | 1.1% | SCHEDULE 13G/A ↗ |
| Apr 20, 2026 | SCHEDULE 13G/A (amended) | CLPT ClearPoint Neuro Inc. | District 2 Capital Fund LP | 341,696 | 1.1% | SCHEDULE 13G/A ↗ |
| Apr 20, 2026 | SCHEDULE 13G/A (amended) | CLPT ClearPoint Neuro Inc. | Bigger Capital Fund GP, LLC | 1.36M | 4.5% | SCHEDULE 13G/A ↗ |
| Apr 20, 2026 | SCHEDULE 13G/A (amended) | CLPT ClearPoint Neuro Inc. | Bigger Capital Fund L P | 1.36M | 4.5% | SCHEDULE 13G/A ↗ |
| Mar 26, 2026 | SCHEDULE 13G/A (amended) | CLPT ClearPoint Neuro Inc. | The Vanguard Group | 0 | 0.0% | SCHEDULE 13G/A ↗ |
| Mar 13, 2026 | SCHEDULE 13G | CLPT ClearPoint Neuro Inc. | Michael A. Kaufman | 1.73M | 6.1% | SCHEDULE 13G ↗ |
| Mar 13, 2026 | SCHEDULE 13G | CLPT ClearPoint Neuro Inc. | Mak Capital One LLC | 1.73M | 6.1% | SCHEDULE 13G ↗ |
| Mar 13, 2026 | SCHEDULE 13G | CLPT ClearPoint Neuro Inc. | MAK Capital Fund LP | 1.73M | 6.1% | SCHEDULE 13G ↗ |
| Feb 4, 2026 | SCHEDULE 13G/A (amended) | CLPT ClearPoint Neuro Inc. | Patricia Winter | 167,000 | 0.0% | SCHEDULE 13G/A ↗ |
| Feb 4, 2026 | SCHEDULE 13G/A (amended) | CLPT ClearPoint Neuro Inc. | Michael Bigger | 2.22M | 7.8% | SCHEDULE 13G/A ↗ |
| Feb 4, 2026 | SCHEDULE 13G/A (amended) | CLPT ClearPoint Neuro Inc. | District 2 Holdings LLC | 337,696 | 1.2% | SCHEDULE 13G/A ↗ |
| Feb 4, 2026 | SCHEDULE 13G/A (amended) | CLPT ClearPoint Neuro Inc. | District 2 GP LLC | 337,696 | 1.2% | SCHEDULE 13G/A ↗ |
| Feb 4, 2026 | SCHEDULE 13G/A (amended) | CLPT ClearPoint Neuro Inc. | District 2 Capital LP | 337,696 | 1.2% | SCHEDULE 13G/A ↗ |
| Feb 4, 2026 | SCHEDULE 13G/A (amended) | CLPT ClearPoint Neuro Inc. | District 2 Capital Fund LP | 337,696 | 1.2% | SCHEDULE 13G/A ↗ |
| Feb 4, 2026 | SCHEDULE 13G/A (amended) | CLPT ClearPoint Neuro Inc. | Bigger Capital Fund GP, LLC | 1.33M | 4.7% | SCHEDULE 13G/A ↗ |
| Feb 4, 2026 | SCHEDULE 13G/A (amended) | CLPT ClearPoint Neuro Inc. | Bigger Capital Fund L P | 1.33M | 4.7% | SCHEDULE 13G/A ↗ |
| Nov 12, 2025 | SCHEDULE 13G/A (amended) | CLPT ClearPoint Neuro Inc. | Patricia Winter | 167,000 | 0.0% | SCHEDULE 13G/A ↗ |
| Nov 12, 2025 | SCHEDULE 13G/A (amended) | CLPT ClearPoint Neuro Inc. | Michael Bigger | 2.15M | 7.6% | SCHEDULE 13G/A ↗ |
| Nov 12, 2025 | SCHEDULE 13G/A (amended) | CLPT ClearPoint Neuro Inc. | District 2 Holdings LLC | 307,753 | 1.1% | SCHEDULE 13G/A ↗ |
| Nov 12, 2025 | SCHEDULE 13G/A (amended) | CLPT ClearPoint Neuro Inc. | District 2 GP LLC | 307,753 | 1.1% | SCHEDULE 13G/A ↗ |
| Nov 12, 2025 | SCHEDULE 13G/A (amended) | CLPT ClearPoint Neuro Inc. | District 2 Capital LP | 307,753 | 1.1% | SCHEDULE 13G/A ↗ |
| Nov 12, 2025 | SCHEDULE 13G/A (amended) | CLPT ClearPoint Neuro Inc. | District 2 Capital Fund LP | 307,753 | 1.1% | SCHEDULE 13G/A ↗ |
| Nov 12, 2025 | SCHEDULE 13G/A (amended) | CLPT ClearPoint Neuro Inc. | Bigger Capital Fund GP, LLC | 1.29M | 4.5% | SCHEDULE 13G/A ↗ |
The newest 50 items, most recent first. Every row links to its original filing. Updated Nov 15, 2026, 6:46 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Planned insider sales · Executive pay · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances